Global Animal Models Used in Tests Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Animal Models Used in Tests market size will reach US$ 3723 million by 2031.
Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process. Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans. In our report, all the animals used in scientific purposes are included.
The Animal Models Used in Tests market is driven by the growing need for reliable and reproducible preclinical data in drug discovery, toxicology studies, and biomedical research. Animal models play a critical role in understanding disease mechanisms, evaluating therapeutic efficacy, and ensuring safety before human trials. The increasing prevalence of chronic and genetic diseases, coupled with the rise in R&D activities by pharmaceutical and biotechnology companies, is fueling the demand for advanced and genetically modified animal models. Additionally, government funding and academic support for translational research are further propelling market growth, especially in areas like oncology, neurology, and infectious diseases.
Despite their importance, the use of animal models in testing faces several challenges, including ethical concerns, high costs, and limitations in accurately mimicking human biology. Regulatory pressures and growing advocacy for animal welfare have led to stricter guidelines and increased demand for alternatives such as organ-on-a-chip and computer-based simulations. Furthermore, the development and maintenance of genetically modified or disease-specific models require significant investment and specialized facilities. The reproducibility crisis in biomedical research, partly due to variability in animal studies, also threatens scientific credibility. Overcoming these issues requires ethical oversight, technological innovation, and balanced integration of alternative methods.
LPI (LP Information)' newest research report, the “Animal Models Used in Tests Industry Forecast” looks at past sales and reviews total world Animal Models Used in Tests sales in 2024, providing a comprehensive analysis by region and market sector of projected Animal Models Used in Tests sales for 2025 through 2031. With Animal Models Used in Tests sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal Models Used in Tests industry.
This Insight Report provides a comprehensive analysis of the global Animal Models Used in Tests landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Animal Models Used in Tests portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Animal Models Used in Tests market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal Models Used in Tests and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal Models Used in Tests.
This report presents a comprehensive overview, market shares, and growth opportunities of Animal Models Used in Tests market by product type, application, key players and key regions and countries.
Segmentation by Type:
Rats
Mice
Others
Segmentation by Application:
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Crown Biosciences
Shanghai SLAC
Shangghai Modelorg
GenOway
Syngene International
Psychogenics
Pharmaron
Pharmalegacy
Vitalstar Biotechnology
JANVIER LABS
Please note: The report will take approximately 2 business days to prepare and deliver.
Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process. Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans. In our report, all the animals used in scientific purposes are included.
The Animal Models Used in Tests market is driven by the growing need for reliable and reproducible preclinical data in drug discovery, toxicology studies, and biomedical research. Animal models play a critical role in understanding disease mechanisms, evaluating therapeutic efficacy, and ensuring safety before human trials. The increasing prevalence of chronic and genetic diseases, coupled with the rise in R&D activities by pharmaceutical and biotechnology companies, is fueling the demand for advanced and genetically modified animal models. Additionally, government funding and academic support for translational research are further propelling market growth, especially in areas like oncology, neurology, and infectious diseases.
Despite their importance, the use of animal models in testing faces several challenges, including ethical concerns, high costs, and limitations in accurately mimicking human biology. Regulatory pressures and growing advocacy for animal welfare have led to stricter guidelines and increased demand for alternatives such as organ-on-a-chip and computer-based simulations. Furthermore, the development and maintenance of genetically modified or disease-specific models require significant investment and specialized facilities. The reproducibility crisis in biomedical research, partly due to variability in animal studies, also threatens scientific credibility. Overcoming these issues requires ethical oversight, technological innovation, and balanced integration of alternative methods.
LPI (LP Information)' newest research report, the “Animal Models Used in Tests Industry Forecast” looks at past sales and reviews total world Animal Models Used in Tests sales in 2024, providing a comprehensive analysis by region and market sector of projected Animal Models Used in Tests sales for 2025 through 2031. With Animal Models Used in Tests sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal Models Used in Tests industry.
This Insight Report provides a comprehensive analysis of the global Animal Models Used in Tests landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Animal Models Used in Tests portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Animal Models Used in Tests market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal Models Used in Tests and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal Models Used in Tests.
This report presents a comprehensive overview, market shares, and growth opportunities of Animal Models Used in Tests market by product type, application, key players and key regions and countries.
Segmentation by Type:
Rats
Mice
Others
Segmentation by Application:
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Crown Biosciences
Shanghai SLAC
Shangghai Modelorg
GenOway
Syngene International
Psychogenics
Pharmaron
Pharmalegacy
Vitalstar Biotechnology
JANVIER LABS
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
104 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Animal Models Used in Tests Market Size by Player
- 4 Animal Models Used in Tests by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Animal Models Used in Tests Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
